No (N=86)	Yes (N=13)	P-value
Age (years)
Mean (SD)	54.9 (9.73)	56.4 (13.4)	0.174
Median [Min, Max]	54.0 [28.0, 82.0]	58.0 [24.0, 79.0]
Operation_history
Direct_surgery	62 (72.1%)	4 (30.8%)	0.00932
Septal_tumor_reduction	1 (1.2%)	0 (0%)
Surgery_after_neoadjuvant	23 (26.7%)	9 (69.2%)
Type
CCC	2 (2.3%)	0 (0%)	0.741
EC	2 (2.3%)	1 (7.7%)
HGSC	77 (89.5%)	12 (92.3%)
LGSC	2 (2.3%)	0 (0%)
MC	2 (2.3%)	0 (0%)
Missing	1 (1.2%)	0 (0%)
Clinical_stage
I	1 (1.2%)	0 (0%)	0.0992
II	8 (9.3%)	0 (0%)
III	42 (48.8%)	3 (23.1%)
IV	35 (40.7%)	10 (76.9%)
TMB_group
High	3 (3.5%)	2 (15.4%)	0.263
Low	81 (94.2%)	11 (84.6%)
Missing	2 (2.3%)	0 (0%)
Planting_metastasis
No	6 (7.0%)	1 (7.7%)	1
Yes	80 (93.0%)	12 (92.3%)
Lymph.node_metastasis
No	37 (43.0%)	4 (30.8%)	0.593
Yes	49 (57.0%)	9 (69.2%)
Type_group
HGSC	77 (89.5%)	12 (92.3%)	1
Non_HGSC	9 (10.5%)	1 (7.7%)